In this DHCG Disruptive Dose episode, Mark Bard of the DHC Group speaks with Nivi Mogali, Director of Enterprise Omnichannel Analytics Capabilities at GSK, about the intersection of data, AI, and patient care. Mongali discusses how pharma companies can responsibly scale AI initiatives by balancing compliance requirements with the pursuit of meaningful patient outcomes. The conversation highlights the need to move beyond ROI and script lift as sole measures of success, emphasizing instead the importance of demonstrating how AI can directly serve patients. Together, they explore how bridging technology, analytics, and care delivery can shape a more impactful and sustainable future for the industry.